291

Professional attendance of more than 45 minutes duration at consulting rooms by a consultant physician in the practice of his or her specialty of psychiatry, if:

 (a) the attendance follows referral of the patient to the consultant for an assessment or management by a medical practitioner in general practice (including a general practitioner, but not a specialist or consultant physician); and

 (b) during the attendance, the consultant:

 (i) uses an outcome tool (if clinically appropriate); and

 (ii) carries out a mental state examination; and

 (iii) makes a psychiatric diagnosis; and

 (c) the consultant decides that it is clinically appropriate for the patient to be managed by the referring medical practitioner without ongoing treatment by the consultant; and

 (d) within 2 weeks after the attendance, the consultant:

 (i) prepares a written diagnosis of the patient; and

 (ii) prepares a written management plan for the patient that:

 (A) covers the next 12 months; and

 (B) is appropriate to the patient’s diagnosis; and

 (C) comprehensively evaluates the patient’s biological, psychological and social issues; and

 (D) addresses the patient’s diagnostic psychiatric issues; and

 (E) makes management recommendations addressing the patient’s biological, psychological and social issues; and

 (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and

218.15

 (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to:

 (A) the patient; and

 (B) the patient’s carer (if any), if the patient agrees);

(Item is subject to rule 88)

293

Professional attendance of more than 30 minutes but not more than 45 minutes duration at consulting rooms by a consultant physician in the practice of his or her specialty of psychiatry, if:

 (a) the patient is being managed by a medical practitioner in accordance with a management plan prepared by the consultant in accordance with item 291; and

 (b)  the attendance follows referral of the patient to the consultant for review of the management plan by the medical practitioner managing the patient; and

 (c) during the attendance, the consultant:

 (i) uses an outcome tool (if clinically appropriate); and

 (ii) carries out a mental state examination; and

 (iii) makes a psychiatric diagnosis; and

 (iv) reviews the management plan; and

136.95

 (d) within 2 weeks after the attendance, the consultant:

 (i) prepares a written diagnosis of the patient; and

 (ii) revises the management plan; and

 (iii) gives the referring medical practitioner a copy of the diagnosis and the revised management plan; and

 (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to:

 (A) the patient; and

 (B) the patient’s carer (if any), if the patient agrees);

(Item is subject to rule 88)

2497

Professional attendance at consulting rooms by a general practitioner:

 (a) involving taking a patient’s selective history, examining the patient and implementing a management plan in relation to 1 or more problems; or

 (b) being an attendance of less than 5 minutes duration;

at which a cervical smear is taken from a woman between the ages of 20 and 69 years (inclusive) who has not had a cervical smear in the last 4 years

14.10

2598

Professional attendance at consulting rooms of less than 5 minutes duration by a medical practitioner who practices in general practice (other than a general practitioner):

 (a) involving taking a patient’s selective history, examining the patient and implementing a management plan in relation to 1 or more problems; and

 (b) at which a cervical smear is taken from a woman between the ages of 20 and 69 years (inclusive) who has not had a cervical smear in the last 4 years

11.00

10916

Professional attendance, being the first in a course of attention, of not more than 15 minutes duration (not being a service associated with a service to which item 10940, 10941 or 10942 applies)

30.15

10942

Testing of residual vision to provide optimum visual performance for a patient who has best corrected visual acuity of 6/15 or N.12 in the better eye or a horizontal visual field of less than 120 degrees and within 10 degrees above and below the horizontal median, involving 1 or more of the following:

 (a) spectacle correction;

 (b) determination of contrast sensitivity;

 (c) determination of glare sensitivity;

 (d) prescription of magnification aids;

not being a service associated with a service to which item 10916, 10921, 10922, 10923, 10924, 10925, 10926, 10927, 10928, 10929 or 10930 applies

(Item is subject to rule 88)

30.15

10999

Service provided by a practice nurse, being the taking of a cervical smear from a woman between the ages of 20 and 69 years (inclusive) who has not had a cervical smear in the last 4 years, if:

 (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and

 (b) the service is provided at, or from, a practice location in a regional, rural or remote area; and

 (c) the person is not an admitted patient of a hospital or approved day hospital facility

10.20

11820

Capsule endoscopy to investigate an episode of obscure gastrointestinal bleeding, using a capsule endoscopy device approved by the Therapeutic Goods Administration (including administration of the capsule, imaging, image reading and interpretation, and all attendances for providing the service on the day the capsule is administered) if:

 (a) the service is performed by a specialist or consultant physician with endoscopic training that is recognised by The Conjoint Committee for the Recognition of Training in Gastrointestinal Endoscopy; and

 (b) the patient to whom the service is provided:

 (i) is aged 10 years or over; and

 (ii) has recurrent or persistent bleeding; and

 (iii) is anaemic or has active bleeding; and

 (c) an upper gastrointestinal endoscopy and a colonoscopy have been performed on the patient and have not identified the cause of the bleeding; and

 (d) the service is performed within 6 months after the upper gastrointestinal endoscopy and colonoscopy

1 730.25

14124

Laser photocoagulation using laser light within the wave length of 510-1064nm in the treatment of haemangiomas of infancy, including any associated consultation — if a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period that commences on the date of the 1st session (Anaes.)

129.40

14218

Implanted infusion pump, refilling of reservoir with a therapeutic agent or agents for infusion to the subarachnoid or epidural space, with or without re‑programming a programmable pump, for the management of chronic intractable pain

83.05

30195

Benign neoplasm of skin, other than viral verrucae (common warts), seborrheic keratoses, cysts and skin tags, treatment by electrosurgical destruction, simple curettage or shave excision, or laser photocoagulation, not being a service to which item 30196, 30197, 30202, 30203 or 30205 applies (1 or more lesions) (Anaes.)

53.85

30375

Caecostomy, enterostomy, colostomy, enterotomy, colotomy, cholecystostomy, gastrostomy, gastrotomy, reduction of intussusception, removal of Meckel’s diverticulum, suture of perforated peptic ulcer, simple repair of ruptured viscus, reduction of volvulus, pyloroplasty (adult) or drainage of pancreas (H) (Anaes.) (Assist.)

442.25

30403

Ventral, incisional, or recurrent hernia or burst abdomen, repair of, with or without mesh (H) (Anaes.) (Assist.)

433.15

30405

Ventral or incisional hernia (other than recurrent inguinal or femoral hernia), repair of, requiring muscle transposition, mesh hernioplasty or resection of strangulated bowel (H) (Anaes.) (Assist.)

760.35

30440

Cholangiogram, percutaneous transhepatic, and insertion of biliary drainage tube, using interventional imaging techniques, not being a service associated with a service to which item 30451 applies (Anaes.) (Assist.)

(Item is subject to rule 89)

446.60

30451

Biliary drainage tube, exchange of, using interventional imaging techniques, not being a service associated with a service to which item 30440 applies (Anaes.) (Assist.)

(Item is subject to rule 89)

227.10

30491

Bile duct, endoscopic stenting of (including endoscopy and dilatation) (Anaes.)

471.20

30492

Bile duct, percutaneous stenting of (including dilatation when performed), using interventional imaging techniques (H) (Anaes.)

(Item is subject to rule 89)

668.00

30493

Biliary manometry (Anaes.)

282.75

30494

Endoscopic biliary dilatation (H) (Anaes.)

356.75

30495

Percutaneous biliary dilatation for biliary stricture using interventional imaging techniques (H) (Anaes.)

(Item is subject to rule 89)

668.00

30514

Morbid obesity, surgical reversal, by any method, of procedure to which item 30511 or 30512 applies (H) (Anaes.) (Assist.)

1 306.00

31255

Basal cell carcinoma or squamous cell carcinoma (including keratocanthoma), removal of, from nose, eyelid, lip, ear, digit or genitalia, if:

 (a) the carcinoma is not more than 10 mm in diameter; and

 (b) the removal is by therapeutic surgical excision (other than shave excision) and suture; and

 (c) the initial specimen removed is sent for histological examination and malignancy is confirmed;

(Anaes.)

187.85

31256

Basal cell carcinoma or squamous cell carcinoma, residual, removal of, from nose, eyelid, lip, ear, digit or genitalia, following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the previous carcinoma was not more than 10 mm in diameter; and

 (b) the removal is performed by the practitioner who removed the previous carcinoma; and

 (c) the removal is by surgical excision (other than shave excision) and suture; and

 (d) the specimen excised is sent for histological examination;

(Anaes.)

187.85

31257

Basal cell carcinoma or squamous cell carcinoma, residual, removal of, from nose, eyelid, lip, ear, digit or genitalia, following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the previous carcinoma was not more than 10 mm in diameter; and

 (b) the removal is performed by a practitioner other than the practitioner who removed the previous carcinoma; and

 (c) the removal is by surgical excision (other than shave excision) and suture; and

 (d) the specimen excised is sent for histological examination;

(Anaes.)

187.85

31258

Basal cell carcinoma or squamous cell carcinoma, recurrent, removal of, from nose, eyelid, lip, ear, digit or genitalia, following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the carcinoma is not more than 10 mm in diameter; and

 (b) the removal is by surgical excision (other than shave excision) and suture; and

 (c) the specimen excised is sent for histological examination and malignancy is confirmed;

not being a service to which item 31295 applies (Anaes.)

187.85

31260

Basal cell carcinoma or squamous cell carcinoma (including keratocanthoma), removal of, from nose, eyelid, lip, ear, digit or genitalia, if:

 (a) the carcinoma is more than 10 mm in diameter; and

 (b) the removal is by therapeutic surgical excision (other than shave excision) and suture; and

 (c) the initial specimen removed is sent for histological examination and malignancy is confirmed;

(Anaes.)

267.85

31261

Basal cell carcinoma or squamous cell carcinoma, residual, removal of, from nose, eyelid, lip, ear, digit or genitalia, following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the previous carcinoma was more than 10 mm in diameter; and

 (b) the removal is performed by the practitioner who removed the previous carcinoma; and

 (c) the removal is by surgical excision (other than shave excision) and suture; and

 (d) the specimen excised is sent for histological examination;

(Anaes.)

267.85

31262

Basal cell carcinoma or squamous cell carcinoma, residual, removal of, from nose, eyelid, lip, ear, digit or genitalia, following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the previous carcinoma was more than 10 mm in diameter; and

 (b) the removal is performed by a practitioner other than the practitioner who removed the previous carcinoma; and

 (c) the removal is by surgical excision (other than shave excision) and suture; and

 (d) the specimen excised is sent for histological examination;

(Anaes.)

267.85

31263

Basal cell carcinoma or squamous cell carcinoma, recurrent, removal of, from nose, eyelid, lip, ear, digit or genitalia, following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the carcinoma is more than 10 mm in diameter; and

 (b) the removal is by surgical excision (other than shave excision) and suture; and

 (c) the specimen excised is sent for histological examination and malignancy is confirmed;

not being a service to which item 31295 applies (Anaes.)

267.85

31265

Basal cell carcinoma or squamous cell carcinoma (including keratocanthoma), removal of, from the face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), if:

 (a) the carcinoma is not more than 10 mm in diameter; and

 (b) the removal is by therapeutic surgical excision (other than shave excision) and suture; and

 (c)  the initial specimen removed is sent for histological examination and malignancy is confirmed;

(Anaes.)

156.50

31266

Basal cell carcinoma or squamous cell carcinoma, residual, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the previous carcinoma was not more than 10 mm in diameter; and

 (b) the removal is performed by the practitioner who removed the previous carcinoma; and

 (c) the removal is by surgical excision (other than shave excision) and suture; and

 (d) the specimen excised is sent for histological examination;

(Anaes.)

156.50

31267

Basal cell carcinoma or squamous cell carcinoma, residual, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the previous carcinoma was not more than 10 mm in diameter; and

 (b) the removal is performed by a practitioner other than the practitioner who removed the previous carcinoma; and

 (c) the removal is by surgical excision (other than shave excision) and suture; and

 (d) the specimen excised is sent for histological examination;

(Anaes.)

156.50

31268

Basal cell carcinoma or squamous cell carcinoma, recurrent, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the carcinoma is not more than 10 mm in diameter; and

 (b) the removal is by surgical excision (other than shave excision) and suture; and

 (c) the specimen excised is sent for histological examination and malignancy is confirmed;

not being a service to which item 31295 applies (Anaes.)

156.50

31270

Basal cell carcinoma or squamous cell carcinoma (including keratocanthoma), removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), if:

 (a) the carcinoma is more than 10 mm and not more than 20 mm in diameter; and

 (b) the removal is by therapeutic surgical excision (other than shave excision) and suture; and

 (c) the initial specimen removed is sent for histological examination and malignancy is confirmed;

(Anaes.)

219.15

31271

Basal cell carcinoma or squamous cell carcinoma, residual, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the previous carcinoma was more than 10 mm and not more than 20 mm in diameter; and

 (b) the removal is performed by the practitioner who removed the previous carcinoma; and

 (c) the removal is by surgical excision (other than shave excision) and suture; and

 (d) the specimen excised is sent for histological examination;

(Anaes.)

219.15

31272

Basal cell carcinoma or squamous cell carcinoma, residual, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the previous carcinoma was more than 10 mm and not more than 20 mm in diameter; and

 (b) the removal is performed by a practitioner other than the practitioner who removed the previous carcinoma; and

 (c) the removal is by surgical excision (other than shave excision) and suture; and

 (d) the specimen excised is sent for histological examination;

(Anaes.)

219.15

31273

Basal cell carcinoma or squamous cell carcinoma, recurrent, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the carcinoma is more than 10 mm and not more than 20 mm in diameter; and

 (b) the removal is by surgical excision (other than shave excision) and suture; and

 (c) the specimen excised is sent for histological examination and malignancy is confirmed;

not being a service to which item 31295 applies (Anaes.)

219.15

31275

Basal cell carcinoma or squamous cell carcinoma (including keratocanthoma), removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), if:

 (a) the carcinoma is more than 20 mm in diameter; and

 (b) the removal is by therapeutic surgical excision (other than shave excision) and suture; and

 (c) the initial specimen removed is sent for histological examination and malignancy is confirmed;

(Anaes.)

253.90

31276

Basal cell carcinoma or squamous cell carcinoma, residual, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the previous carcinoma was more than 20 mm in diameter; and

 (b) the removal is performed by the practitioner who removed the previous carcinoma; and

 (c) the removal is by surgical excision (other than shave excision) and suture; and

 (d) the specimen excised is sent for histological examination;

(Anaes.)

253.90

31277

Basal cell carcinoma or squamous cell carcinoma, residual, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the previous carcinoma was more than 20 mm in diameter; and

 (b) the removal is performed by a practitioner other than the practitioner who removed the previous carcinoma; and

 (c) the removal is by surgical excision (other than shave excision) and suture; and

 (d) the specimen excised is sent for histological examination;

(Anaes.)

253.90

31278

Basal cell carcinoma or squamous cell carcinoma, recurrent, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the carcinoma is more than 20 mm in diameter; and

 (b) the removal is by surgical excision (other than shave excision) and suture; and

 (c) the specimen excised is sent for histological examination and malignancy is confirmed;

not being a service to which item 31295 applies (Anaes.)

253.90

31280

Basal cell carcinoma or squamous cell carcinoma (including keratocanthoma), removal of, from an area of the body not covered by item 31255 or 31265, if:

 (a) the carcinoma is not more than 10 mm in diameter; and

 (b) the removal is by therapeutic surgical excision (other than shave excision) and suture; and

 (c) the initial specimen removed is sent for histological examination and malignancy is confirmed;

(Anaes.)

132.75

31281

Basal cell carcinoma or squamous cell carcinoma, residual, removal of, from an area of the body not covered by item 31255 or 31265, following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the previous carcinoma was not more than 10 mm in diameter; and

 (b) the removal is performed by the practitioner who removed the previous carcinoma; and

 (c) the removal is by surgical excision (other than shave excision) and suture; and

 (d) the specimen excised is sent for histological examination;

(Anaes.)

132.75

31282

Basal cell carcinoma or squamous cell carcinoma, residual, removal of, from an area of the body not covered by item 31255 or 31265, following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the previous carcinoma was not more than 10 mm in diameter; and

 (b) the removal is performed by a practitioner other than the practitioner who removed the previous carcinoma; and

 (c) the removal is by surgical excision (other than shave excision) and suture; and

 (d) the specimen excised is sent for histological examination;

(Anaes.)

132.75

31283

Basal cell carcinoma or squamous cell carcinoma, recurrent, removal of, from an area of the body not covered by item 31255 or 31265, following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the carcinoma is not more than 10 mm in diameter; and

 (b) the removal is by surgical excision (other than shave excision) and suture; and

 (c) the specimen excised is sent for histological examination and malignancy is confirmed;

(Anaes.)

132.75

31285

Basal cell carcinoma or squamous cell carcinoma (including keratocanthoma), removal of, from an area of the body not covered by item 31260 or 31270, if:

 (a) the carcinoma is more than 10 mm and not more than 20 mm in diameter; and

 (b) the removal is by therapeutic surgical excision (other than by shave excision) and suture; and

 (c) the initial specimen removed is sent for histological examination and malignancy is confirmed;

(Anaes.)

180.75

31286

Basal cell carcinoma or squamous cell carcinoma, residual, removal of, from an area of the body not covered by item 31260 or 31270, following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the previous carcinoma was more than 10 mm and not more than 20 mm in diameter; and

 (b) the removal is performed by the practitioner who removed the previous carcinoma; and

 (c) the removal is by surgical excision (other than shave excision) and suture; and

 (d) the specimen excised is sent for histological examination;

(Anaes.)

180.75

31287

Basal cell carcinoma or squamous cell carcinoma, residual, removal of, from an area of the body not covered by item 31260 or 31270, following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the previous carcinoma was more than 10 mm and not more than 20 mm in diameter; and

 (b) the removal is performed by a practitioner other than the practitioner who removed the previous carcinoma; and

 (c) the removal is by surgical excision (other than shave excision) and suture; and

 (d) the specimen excised is sent for histological examination;

(Anaes.)

180.75

31288

Basal cell carcinoma or squamous cell carcinoma, recurrent, removal of, from an area of the body not covered by item 31260 or 31270, following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the carcinoma is more than 10 mm and not more than 20 mm in diameter; and

 (b) the removal is by surgical excision (other than shave excision) and suture; and

 (c) the specimen excised is sent for histological examination and malignancy is confirmed;

(Anaes.)

180.75

31290

Basal cell carcinoma or squamous cell carcinoma (including keratocanthoma), removal of, from an area of the body not covered by item 31260 or 31275, if:

 (a) the carcinoma is more than 20 mm in diameter; and

 (b) the removal is by therapeutic surgical excision (other than shave excision) and suture; and

 (c) the initial specimen removed is sent for histological examination and malignancy is confirmed;

(Anaes.)

208.65

31291

Basal cell carcinoma or squamous cell carcinoma, residual, removal of, from an area of the body not covered by item 31260 or 31275, following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the previous carcinoma was more than 20 mm in diameter; and

 (b) the removal is performed by the practitioner who removed the previous carcinoma; and

 (c) the removal is by surgical excision (other than shave excision) and suture; and

 (d) the specimen excised is sent for histological examination;

(Anaes.)

208.65

31292

Basal cell carcinoma or squamous cell carcinoma, residual, removal of, from an area of the body not covered by item 31260 or 31275, following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the previous carcinoma was more than 20 mm in diameter; and

 (b) the removal is performed by a practitioner other than the practitioner who removed the previous carcinoma; and

 (c) the removal is by surgical excision (other than shave excision) and suture; and

 (d) the specimen excised is sent for histological examination;

(Anaes.)

208.65

31293

Basal cell carcinoma or squamous cell carcinoma, recurrent, removal of, from an area of the body not covered by item 31260 or 31275, following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the carcinoma is more than 20 mm in diameter; and

 (b) the removal is by surgical excision (other than shave excision) and suture; and

 (c) the specimen excised is sent for histological examination and malignancy is confirmed;

(Anaes.)

208.65

31295

Basal cell carcinoma or squamous cell carcinoma, recurrent, removal of, from the head or neck (anterior to the sternomastoid muscles), following the removal of a previous basal cell carcinoma or squamous cell carcinoma at that site, if:

 (a) the previous carcinoma was treated by previous surgery, serial cautery and curettage, radiotherapy or 2 prolonged freeze and thaw cycles of liquid nitrogen therapy; and

 (b) the removal is performed by:

 (i) a specialist in the practice of his or her specialty; or

 (ii) a practitioner other than the practitioner who removed the previous carcinoma; and

 (c) the removal is by surgical excision and suture; and

 (d) the specimen excised is sent for histological examination and malignancy is confirmed;

(Anaes.)

248.50

35331

Retrieval of inferior vena caval filter, percutaneous or by open exposure, not including associated radiological services or preparation, and not including aftercare (H) (Anaes.)

502.70

35360

Retrieval of foreign body in pulmonary artery, percutaneous or by open exposure, not including associated radiological services or preparation, and not including aftercare (H) (Anaes.) (Assist.)

702.70

35361

Retrieval of foreign body in right atrium, percutaneous or by open exposure, not including associated radiological services or preparation, and not including aftercare (H) (Anaes.) (Assist.)

602.70

35362

Retrieval of foreign body in inferior vena cava or aorta, percutaneous or by open exposure, not including associated radiological services or preparation, and not including aftercare (H) (Anaes.) (Assist.)

502.70

35363

Retrieval of foreign body in peripheral vein or peripheral artery, percutaneous or by open exposure, not including associated radiological services or preparation, and not including aftercare (H) (Anaes.) (Assist.)

402.70

35568

Sacrospinous colpopexy for the management of upper vaginal prolapse (H) (Anaes.) (Assist.)

530.00

35569

Plastic repair to enlarge vaginal orifice (H) (Anaes.)

136.45

35570

Anterior vaginal compartment repair by vaginal approach (involving repair of urethrocele and cystocele), with or without mesh, not being a service associated with a service to which item 35573, 35577 or 35578 applies (H) (Anaes.) (Assist.)

470.00

35571

Posterior vaginal compartment repair by vaginal approach involving repair of one or more of the following:

 (a) perineum;

 (b) rectocoele;

 (c) enterocoele;

with or without mesh, not being a service associated with a service to which item 35573, 35577 or 35578 applies (H) (Anaes.) (Assist.)

470.00

35572

Colpotomy, not being a service to which another item in this group applies (H) (Anaes.)

105.05

35573

Anterior and posterior vaginal compartment repair by vaginal approach (involving anterior and posterior compartment defects), with or without mesh, not being a service associated with a service to which item 35577 or 35578 applies (H) (Anaes.) (Assist.)

705.00

35577

Manchester (Donald Fothergill) operation for genital prolapse, with or without mesh (H) (Anaes.) (Assist.)

572.30

35578

Le Fort operation for genital prolapse, not being a service associated with a service to which another item in this subgroup applies (H) (Anaes.) (Assist.)

572.30

35595

Laparoscopic or abdominal pelvic floor repair involving the fixation of the uterosacral and cardinal ligaments to rectovaginal and pubocervical fascia for symptomatic upper vaginal vault prolapse (H) (Anaes.) (Assist.)

980.00

35596

Fistula between genital and urinary or alimentary tracts, repair of, not being a service to which item 37029, 37333 or 37336 applies (H) (Anaes.) (Assist.)

580.25

35597

Sacral colpopexy, laparoscopic or open procedure, if graft or mesh is secured to the vault, the anterior and posterior compartments and to the sacrum for correction of symptomatic upper vaginal vault prolapse (H) (Anaes.) (Assist.)

1 250.00

35599

Stress incontinence, sling operation for, with or without mesh or tape, not being a service associated with a service to which item 30405 applies (H) (Anaes.) (Assist.)

572.30

35617

Cervix, cone biopsy, amputation or repair of, not being a service to which item 35577 or 35578 applies (G) (Anaes.)

147.35

35618

Cervix, cone biopsy, amputation or repair of, not being a service to which item 35577 or 35578 applies (S) (Anaes.)

184.95

36605

Ureteric stent, insertion of, with removal of calculus from:

 (a) the pelvicalyceal system; or

 (b) ureter; or

 (c) the pelvicalyceal system and ureter;

through a nephrostomy tube using interventional imaging techniques (H) (Anaes.)

586.00

36606

Intestinal urinary reservoir, continent, formation of, including formation of non-return valves and implantation of ureters (1 or both) into reservoir (H) (Anaes.) (Assist.)

1 964.95

36607

Ureteric stent, insertion of, with balloon dilatation of:

 (a) the pelvicalyceal system; or

 (b) ureter; or

 (c) the pelvicalyceal system and ureter;

through a nephrostomy tube using interventional imaging techniques (H) (Anaes.)

586.00

36608

Ureteric stent, exchange of, percutaneously through the ileal conduit or bladder using interventional imaging techniques, not being a service associated with a service to which any of items 36811 to 36854 apply (H) (Anaes.)

227.10

36650

Nephrostomy tube, removal of, using interventional imaging techniques, if the ureter has been stented with a double J ureteric stent and that stent is left in place (H) (Anaes.)

127.00

39125

Intrathecal or epidural spinal catheter, insertion or replacement of, and connection to a subcutaneous implanted infusion pump, for the management of chronic intractable pain (H) (Anaes.) (Assist.)

252.90

39126

All of the following:

 (a) infusion pump, subcutaneous implantation or replacement of;

 (b) connection of the pump to an intrathecal or epidural spinal catheter;

 (c) filling of reservoir with a therapeutic agent or agents;

with or without programming the pump, for the management of chronic intractable pain (H) (Anaes.) (Assist.)

307.05

39127

Subcutaneous reservoir and spinal catheter, insertion of, for the management of chronic intractable pain (H) (Anaes.)

401.90

39128

All of the following:

 (a) infusion pump, subcutaneous implantation of;

 (b) intrathecal or epidural spinal catheter, insertion of;

 (c) connection of pump to catheter;

 (d) filling of reservoir with a therapeutic agent or agents;

with or without programming the pump, for the management of chronic intractable pain (H) (Anaes.) (Assist.)

559.95

39133

Either:

 (a) subcutaneously implanted infusion pump, removal of; or

 (b) intrathecal or epidural spinal catheter, removal or repositioning of;

for the management of chronic intractable pain (H) (Anaes.)

135.30